Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Cash Earnings per Share (CEPS)

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

NATH BIOGENES (INDIA) Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
   CEPS(Rs) 22.3222.5620.01-33.8410.16

What is the latest Cash Earnings per Share (CEPS) ratio of NATH BIOGENES (INDIA) ?

The latest Cash Earnings per Share (CEPS) ratio of NATH BIOGENES (INDIA) is 22.32 based on Mar2025 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar202522.32
Mar202422.56
Mar202320.01
Mar2022-33.84
Mar201310.16

How is Cash Earnings per Share (CEPS) of NATH BIOGENES (INDIA) Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2025 22.32
-1.06
Mar2024 22.56
12.74
Mar2023 20.01
Positive
Mar2022 -33.84
Negative
Mar2013 10.16 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Cash Earnings per Share (CEPS) ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹330.2 Cr 18.3% 19% 9.7% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,440.7 Cr 1.6% -5% -14.6% Stock Analytics
KAVERI SEED COMPANY ₹4,760.9 Cr 2.4% 15.7% -31.2% Stock Analytics
VENKYS (INDIA) ₹2,111.8 Cr 2.9% 16.4% -6.7% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,077.6 Cr -4.7% 23.2% -15.5% Stock Analytics
INDO US BIOTECH ₹214.6 Cr 1.2% 7.8% -32.4% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

18.3%

19%

9.7%

SENSEX

4.7%

-0.1%

3.6%


You may also like the below Video Courses